Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001264124-05-000167
Filing Date
2005-05-26
Accepted
2005-05-26 19:01:41
Documents
2
Period of Report
2005-05-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3551
2 EDGAR SUPPORTING DOCUMENT greenepoa.txt EX-24 2120
  Complete submission text file 0001264124-05-000167.txt   7511
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9360 TOWNE CENTRE DR #100 SAN DIEGO CA 92121
Business Address 6195522200
GREENE HOWARD E JR (Reporting) CIK: 0000903574 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 05861294